Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry.

Purpose: To investigate the prevalence of xanthine oxidase (XO) inhibitors prescription at admission and discharge in elderly hospital in-patients, to analyze the appropriateness of their use in relation to evidence-based indications, to evaluate the predictors of inappropriate prescription at disch...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 70; no. 12; pp. 1495 - 1504
Autores principales: Pasina, L., Brucato, A., Djade, C., Di Corato, P., Ghidoni, S., Tettamanti, M., Franchi, C., Salerno, F., Corrao, S., Marengoni, A., Marcucci, M., Mannucci, P., Nobili, A.
Formato: research tables/charts Journal Article
Publicado: Springer Nature Dec2014
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103914493&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 103914493
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Dec2014
      vid: 70
      iid: 12
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        103914493
        99347226
        10.1007/s00228-014-1752-4
        NLM25228251
        103914493
      ppf: 1495
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry.
      aug:
        au:
          Pasina, L.
          Brucato, A.
          Djade, C.
          Di Corato, P.
          Ghidoni, S.
          Tettamanti, M.
          Franchi, C.
          Salerno, F.
          Corrao, S.
          Marengoni, A.
          Marcucci, M.
          Mannucci, P.
          Nobili, A.
        affil: Laboratory for Quality Assessment of Geriatric Therapies and Services, Drug Information Service for the Elderly, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa, 19 20156 Milan Italy
      sug:
        subj:
          Inappropriate Prescribing
          Allopurinol Administration and Dosage
          Gout Suppressants Administration and Dosage
          Allopurinol Adverse Effects
          Gout Suppressants Adverse Effects
          Registries, Disease
          Gout Drug Therapy
          Adverse Drug Event
          Human
          Cross Sectional Studies
          Italy
          Aged
          Descriptive Statistics
          Patient Discharge
          Scales
          Analysis of Variance
          Data Analysis Software
          Confidence Intervals
          Odds Ratio
          Aged, 80 and Over
          Male
          Female
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Purpose: To investigate the prevalence of xanthine oxidase (XO) inhibitors prescription at admission and discharge in elderly hospital in-patients, to analyze the appropriateness of their use in relation to evidence-based indications, to evaluate the predictors of inappropriate prescription at discharge and the association with adverse events 3 months after hospital discharge. Methods: This cross-sectional study, based upon a prospective registry, was held in 95 Italian internal medicine and geriatric hospital wards. The sample included 4035 patients aged 65 years or older at admission and 3502 at discharge. The prescription of XO inhibitors was considered appropriate in patients with diagnosis of gout, gout nephropathy, uric acid nephrolithiasis, tophi, and chemotherapy-induced hyperuricemia. In order to evaluate the predictors of inappropriate prescription of XO inhibitors, we compared the characteristics of patients considered inappropriately treated with those appropriately not treated. Results: Among the 4035 patients eligible for the analysis, 467 (11.6 %) were treated with allopurinol or febuxostat at hospital admission and 461 (13.2 %) among 3502 patients discharged. At admission, 39 (8.6 %) of patients receiving XO inhibitors and 43 (9.4 %) at discharge were appropriately treated. Among those inappropriately treated, hyperuricemia, polytherapy, chronic renal failure, diabetes, obesity, ischemic cardiomyopathy, heart failure, and cardiac dysrhythmias were associated with greater prescription of XO inhibitors. Prescription of XO inhibitors was associated with a higher risk of adverse clinical events in univariate and multivariate analysis. Conclusions: Prevalence of inappropriate prescription of XO inhibitors remained almost the same at admission and discharge. Inappropriate use of these drugs is principally related to treatment of asymptomatic hyperuricemia and various cardiovascular diseases.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N